GGrantIndex
Sort

53,477 grants matching addiction

Behavioral Economic Analysis of Polydrug Abuse

$433,694
Gail D Winger · University Of Michigan At Ann Arbor · R01 · FY2007 · DA

Genetic Influences on Dual Processing Modes of Reward and Punishment Learning

$433,688
W Todd Todd Maddox · University Of Texas At Austin · R01 · FY2015 · DA

A Novel Strategy for Combating Obesity: Reprogramming Neural Circuits

$433,667
Kay Maxine Tye · Massachusetts Institute Of Technology · DP2 · FY2018 · DK

Alcohol Actions-Molecular Targets on Brain Proteins

$433,661
Robert Adron Harris · University Of Texas At Austin · R01 · FY2009 · AA

Glucocorticoid-regulated endocannabinoids and stress-potentiated cocaine seeking

$433,574
John R Mantsch · Marquette University · R01 · FY2016 · DA

Fos, Jun & synaptic plasticity

$433,566
Giovanni Bosco · University Of Arizona · R01 · FY2006 · DA

Multigenerational Epigenetic Effects of Cannabis Exposure

$433,555
Yasmin L Hurd · Icahn School Of Medicine At Mount Sinai · R01 · FY2013 · DA

Administrative Core

$433,554
Melissa L Walls · Johns Hopkins University · P50 · FY2023 · DA

Technologies and Resources for Core Laboratories

$433,529
Laura F Gibson · West Virginia University · U54 · FY2018 · GM

Postdoctoral Training in the Biology of Drug Abuse

$433,473
John R Traynor · University Of Michigan At Ann Arbor · T32 · FY2020 · DA

Project 2

$433,466
Linda J. Porrino · Wake Forest University Health Sciences · P50 · FY2017 · DA

The National Drug Abuse Treatment Clinical Trials Network

$433,383
Walter Nmn Ling · University Of California Los Angeles · U10 · FY2012 · DA

Targeting of alpha7 nAChR for therapeutic effects

$433,328
Roger L Papke · University Of Florida · R01 · FY2012 · GM

Project 2: Reversing resistance caused by lineage plasticity through epigenetic therapy

$433,322
Yu Chen · Sloan-Kettering Inst Can Research · U54 · FY2017 · CA

Medications Development for Drug Abuse Disorders

$433,294
Eric C Strain · Johns Hopkins University · R01 · FY2010 · DA

Virtual Reality as an Opioid Sparing Treatment for Chronic Pain

$433,256
William Todd Maddox · Appliedvr, Inc. · R44 · FY2020 · DA

Multivalent Vaccine for Opiate Addiction

$433,232
Paul Pentel · Hennepin Healthcare Research Institute · R01 · FY2012 · DA

Automated Assessment of Maternal Sensitivity to Infant Distress: Leveraging Wearable Sensors for Substance Use Disorder Prevention and Research

$433,219
Kaya De Barbaro · University Of Texas At Austin · R01 · FY2024 · DA

Communicating about Nicotine and Differential Risks of Tobacco Products

$433,205
Lyudmila Popova · Georgia State University · R01 · FY2021 · CA

Treatment of cancer pain by lipid mediator Resolvin D1: role of Prostaglandin and Endocannabinoid signaling

$433,204
Sergey G Khasabov · University Of Minnesota · R01 · FY2023 · CA

Technologies and Resources for Core Laboratories

$433,182
Laura F Gibson · West Virginia University · U54 · FY2021 · GM

The role of stress physiology and reproductive hormones in the relationship between cannabis use and sleep in women of childbearing age

$433,145
Andrea Marie Spaeth · Rutgers, The State Univ Of N.J. · R01 · FY2025 · DA

Dissecting the Abuse Liability of Synthetic Cathinone Stimulants

$433,125
Michael A Taffe · Scripps Research Institute, The · R01 · FY2018 · DA

Dissecting the Abuse Liability of Synthetic Cathinone Stimulants

$433,125
Michael A Taffe · Scripps Research Institute, The · R01 · FY2016 · DA

Relapse-suppressing brain mechanisms in alcoholism: role of the mPFC

$433,125
Nobuyoshi Suto · Scripps Research Institute, The · R01 · FY2018 · AA